Literature DB >> 29089219

Known, new and emerging risk factors of hepatocellular carcinoma (review).

Dorra Trad1, Norsaf Bibani2, Meriam Sabbah3, Hela Elloumi4, Dalila Gargouri5, Asma Ouakaa6, Jamel Kharrat7.   

Abstract

Hepatocellular carcinoma (HCC) is the commonest primary cancer of the liver and is a leading cause of cancer-related death worldwide. And despite effective treatment of hepatitis B and C infection which is the prominent factor associated with HCC, the prevalence of this malignancy continues to rise probably due to other factors. So that, identifying risk factor of HCC is essential and effective surveillance programs are necessary in order to maximize patient outcomes. This article summarizes the known, new and emerging risk factors of HCC.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 29089219     DOI： 10.1016/j.lpm.2017.09.025

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


  6 in total

1.  At-a-glance - Cancer trends in Canada, 1984 to 2015.

Authors:  Alain A Demers; Darren R Brenner; Leah Smith; Amanda Shaw
Journal:  Health Promot Chronic Dis Prev Can       Date:  2019-11       Impact factor: 3.240

2.  Update on cancer incidence trends in Canada, 1984 to 2017.

Authors:  Alain A Demers; Nathalie Saint-Jacques; Larry Ellison; Darren Brenner; Natalie Fitzgerald; Samina Aziz; Donna Turner
Journal:  Health Promot Chronic Dis Prev Can       Date:  2022-07       Impact factor: 2.725

Review 3.  The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma.

Authors:  BoZhi Liu; YongChao Zhang; Hui Chen; Wei Li; Emmanuel Tsochatzis
Journal:  Cochrane Database Syst Rev       Date:  2022-01-04

4.  Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study.

Authors:  Ulus Salih Akarca; Belkis Unsal; Orhan Sezgin; Kendal Yalcin; Meral Akdogan; Can Gonen; Feyza Gunduz; Seren Ozenirler; Abdullah Sonsuz; Dinc Dincer; Salim Basol Tekin; Idris Yucel; Hakan Akbulut; Canan Alkım; Ozgur Ozyilkan; Arzu Baygul; Zeynep Merve Cevik; Ramazan Idilman; On Behalf Of K Registry Study Group
Journal:  Turk J Gastroenterol       Date:  2021-12       Impact factor: 1.555

Review 5.  A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed.

Authors:  Shuncong Wang; Yewei Liu; Yuanbo Feng; Jian Zhang; Johan Swinnen; Yue Li; Yicheng Ni
Journal:  Cancers (Basel)       Date:  2019-11-13       Impact factor: 6.639

6.  DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection.

Authors:  Shuncong Wang; Haiqing Ma; Xuemin Li; Xiangqiong Mo; Haiyu Zhang; Lewei Yang; Yun Deng; Yan Yan; Guangwei Yang; Xingwei Liu; Huanhuan Sun
Journal:  Aging (Albany NY)       Date:  2020-01-24       Impact factor: 5.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.